MedTrace Logo

Key Performance Indicators for the Assessment of NSCLC Patients Pathway

NCT04676321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 430

Last updated 2020-12-21

No results posted yet for this study

Summary

This is a multicenter, observational study involving a retrospective collection of data. A total of potential 16 key performance indicators (KPIs) had been developed from a panel of experts (clinicians, IT experts, etc..) to investigate the appropriateness of care in NSCLC patients, with a special focus on the use of immunotherapy. The eligible population and data will be gathered retrospectively using an algorithm. Administrative databases will be used as unique resource: to identify target population and to collect patient's data with which measure KPIs.

Conditions

  • Non Small Cell Lung Cancer

Interventions

OTHER

Patient pathway

Investigation on the appropriateness and quality of NSCLC care among participating sites

Sponsors & Collaborators

  • Azienda USL Reggio Emilia - IRCCS

    collaborator OTHER_GOV

  • Azienda Ospedaliera Universitaria Policlinico

    collaborator OTHER

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

    lead OTHER

Principal Investigators

  • Mattia Altini, Master · IRST

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-10-15
Completion
2020-11-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04676321 on ClinicalTrials.gov